Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Clinical Evidence & Research Findings The published research behind AOD-9604 and Tesamorelin tells two very different stories: AOD-9604s early efficacy signal didnt hold up in its largest trial, while Tesamorelins did which is the central reason one reached FDA approval and the other didnt
For more on this peptide, see our BPC-157 profile, BPC-157 side effects guide, BPC-157 before and after results, and BPC-157 and alcohol interactions
Your practitioner will recommend a treatment plan based on your individual needs and goals
These benefits of BPC 157 suggest potential off-label use for sprains and minor tears to shorten rehabilitation and ease chronic stiffness
US$ 26.51
US$ 20.03
US$ 26.52
US$ 27.93
US$ 20.94
US$ 22.11
US$ 20.71
US$ 25.16
US$ 20.81
